Danger of E-Cigarettes: Official Warning in Kazakhstan

Regulations by 2FIRSTS.ai
Nov.22.2023
Danger of E-Cigarettes: Official Warning in Kazakhstan
Kazakhstan issues warning on dangers of e-cigarettes, including potential lung diseases and physical injuries from explosions and burns.

According to a report by Kazakhstani media outlet YCTNHKA LIVE on November 22nd, Kazakhstan has issued a warning about the dangers of e-cigarettes.

 

The department states that e-cigarettes may lead to serious lung diseases, cardiovascular disorders, and physical injuries, such as burn injuries caused by explosions and malfunctions.

 

The department pointed out that when heating e-liquid in e-cigarettes, which contains ingredients such as propylene glycol, glycerin, nicotine, and flavorings, a chemical reaction may occur, potentially resulting in the production of new chemical substances. When these substances enter lung tissues, they may cause damage to the pulmonary system and even have fatal consequences.

 

The danger of smoking e-cigarettes lies in nicotine itself, which may have a concentration that exceeds that of regular cigarettes by up to ten times.

 

According to statistical data, 9.8% of teenagers between the ages of 11 and 15 in Kazakhstan use e-cigarettes.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

ARAC to 2Firsts | FDA’s Nicotine Pouch Pilot: What Hasn’t Changed Matters Most
ARAC to 2Firsts | FDA’s Nicotine Pouch Pilot: What Hasn’t Changed Matters Most
In a contribution to 2Firsts, U.S. regulatory consultancy ARAC analyzes the FDA’s nicotine pouch PMTA pilot, cautioning that core evidentiary standards remain unchanged. The firm warns against overinterpreting the pilot and urges companies to act now rather than wait for uncertain regulatory shifts.
Oct.21
Expert Warns in 2Firsts Op-ed: Proposed COP11 Ban on Nicotine Pouches Would Be a Global Public Health Mistake
Expert Warns in 2Firsts Op-ed: Proposed COP11 Ban on Nicotine Pouches Would Be a Global Public Health Mistake
As global delegates prepare for COP11, a leaked EU position paper has sparked fresh debate over the future of nicotine pouch regulation. In an exclusive op-ed submitted to 2Firsts, Dr. Nveed Chaudhary, Chair of GINN’s Scientific Committee, argues that banning nicotine pouches would be a profound public health mistake—one that ignores harm reduction science and risks reversing global progress in smoking cessation.
Nov.03
UK Advocacy Groups Launch "20IsPlenty" Campaign for Nicotine Pouch Strength Limit of 20mg
UK Advocacy Groups Launch "20IsPlenty" Campaign for Nicotine Pouch Strength Limit of 20mg
UK harm reduction groups led by We Vape have launched the “20IsPlenty” campaign calling for a 20mg nicotine pouch cap, a ban on youth advertising, and evidence-based regulation. The initiative coincides with the Tobacco and Vapes Bill debate and aims to ensure pouches remain accessible as safer alternatives for smokers.
Oct.28 by 2FIRSTS.ai
KT&G Nears ASF Acquisition, Preparing Wide Regional Nicotine Pouch Expansion
KT&G Nears ASF Acquisition, Preparing Wide Regional Nicotine Pouch Expansion
South Korean outlet nate reports that KT&G expects to finalize its acquisition of Nordic nicotine pouch maker ASF within this year. Beginning next year, the company plans to expand the business well beyond ASF’s current five Nordic markets to Europe, the Middle East, Africa, Asia and North America, supported by its cooperation framework with Altria.
Nov.25
Product | LOST MARY, ELFBAR & VOZOL Debut 2 mL Replaceable-Pod Devices: Three-Model Comparison
Product | LOST MARY, ELFBAR & VOZOL Debut 2 mL Replaceable-Pod Devices: Three-Model Comparison
Several brands launch 2 mL replaceable-pod vapes—Lost Mary Glayce, ELFBAR ELFA “Stein,” VOZOL SLEEK—highlighting rechargeability, pod swaps, and a compliance- and sustainability-led trend.
Oct.27 by 2FIRSTS.ai
British American Tobacco’s VELO Launches Limited McLaren F1 Edition: US Price Only 60% of EU/UK
British American Tobacco’s VELO Launches Limited McLaren F1 Edition: US Price Only 60% of EU/UK
BAT’s VELO has released a McLaren F1 co-branded, track-themed limited-edition pack in McLaren’s orange-black livery. Pricing is about $4.60 per can in the U.S. versus ~$7.40 in the EU/UK. The collaboration extends BAT’s partnership with McLaren dating back to 2019.
Oct.11 by 2FIRSTS.ai